Compare SkyWest Inc (SKYW) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SkyWest Inc vs Sanofi SA — how do they compare? SkyWest Inc trades at $96.26 (market cap $3.73B), while Sanofi SA trades at $42.96 (market cap $103.41B). The key difference: Sanofi SA is far larger — about 27.7× SkyWest Inc's market cap, and Sanofi SA pays a 5.65% dividend while SkyWest Inc pays none. Which is the better fit depends on your goals.
| SKYW | SNY | |
|---|---|---|
Market Cap | $3.73B | $103.41B |
Sector | Technology | Health |
52-Week High | $115.94 | $52.34 |
52-Week Low | $78.40 | $41.33 |
Enterprise Value | $5.51B | $123.44B |
Dividend Yield | — | 5.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SkyWest (SKYW) trades at $94.98, down 4.12% on the day, amid a bearish technical signal. The stock shows attractive valuation with a P/E of 9.53 and P/S of 0.93, supported by a 9.78% net income margin. Recent Q2 2026 earnings missed estimates at $2.54 EPS, but fleet expansion and buybacks underpin positive sentiment. Support lies at $94, with resistance at $97.
Outlook remains cautiously optimistic due to low valuation and strong cash flow, though earnings volatility and insider selling pose risks. Analyst consensus is bullish with a $112 price target, suggesting 18% upside from current levels if operational execution improves.
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
